Leina Sun

577 total citations
21 papers, 435 citations indexed

About

Leina Sun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Leina Sun has authored 21 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Leina Sun's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Leina Sun is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Leina Sun collaborates with scholars based in China and Canada. Leina Sun's co-authors include Qiang Zhang, Zhenfa Zhang, Changli Wang, Baocun Sun, Zhongli Zhan, Dongsheng Yue, Ziliang Jin, Richeng Jiang, Zhujun Liu and Kai Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Leina Sun

21 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leina Sun China 10 241 183 160 135 67 21 435
Elena Vagia United States 9 256 1.1× 125 0.7× 226 1.4× 153 1.1× 82 1.2× 25 493
Surein Arulananda Australia 9 228 0.9× 205 1.1× 230 1.4× 83 0.6× 50 0.7× 28 469
Hongge Liang China 10 176 0.7× 174 1.0× 146 0.9× 57 0.4× 41 0.6× 26 369
W Kitonyi Grace Canada 2 233 1.0× 121 0.7× 114 0.7× 86 0.6× 95 1.4× 2 351
Alberto Verlicchi Italy 12 268 1.1× 228 1.2× 175 1.1× 120 0.9× 25 0.4× 25 421
Qifeng Ding China 10 169 0.7× 149 0.8× 130 0.8× 86 0.6× 57 0.9× 22 386
Trine Lindsted United States 7 254 1.1× 158 0.9× 208 1.3× 91 0.7× 86 1.3× 10 439
Chris Nevala-Plagemann United States 8 280 1.2× 72 0.4× 107 0.7× 107 0.8× 56 0.8× 28 398
Guiqi Zhu China 8 128 0.5× 83 0.5× 147 0.9× 137 1.0× 89 1.3× 13 376
Markus Bernhardt Germany 8 274 1.1× 97 0.5× 193 1.2× 176 1.3× 64 1.0× 26 461

Countries citing papers authored by Leina Sun

Since Specialization
Citations

This map shows the geographic impact of Leina Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leina Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leina Sun more than expected).

Fields of papers citing papers by Leina Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leina Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leina Sun. The network helps show where Leina Sun may publish in the future.

Co-authorship network of co-authors of Leina Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Leina Sun. A scholar is included among the top collaborators of Leina Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leina Sun. Leina Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qiang, Yu Zhang, Hui Chen, et al.. (2025). Dual-functional injectable adhesive hydrogel delivering ginger-derived doxorubicin vesicles for osteosarcoma recurrence suppression and post-resection wound healing. Frontiers in Bioengineering and Biotechnology. 13. 1609673–1609673. 1 indexed citations
2.
Zhang, Qiang, Yu Zhang, Leina Sun, et al.. (2024). Injectable hydrogel with doxorubicin-loaded ZIF-8 nanoparticles for tumor postoperative treatments and wound repair. Scientific Reports. 14(1). 9983–9983. 25 indexed citations
3.
Guo, Jingjing, et al.. (2023). [Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and
Migration of Small Cell Lung Cancer with High c-Myc Expression].. SHILAP Revista de lepidopterología. 26(2). 105–112. 1 indexed citations
4.
Sun, Leina, et al.. (2023). CT‐based radiomics model to predict spread through air space in resectable lung cancer. Cancer Medicine. 12(18). 18755–18766. 6 indexed citations
5.
Chen, Qin, et al.. (2023). Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review. Frontiers in Oncology. 13. 1227980–1227980. 8 indexed citations
6.
Zhao, Xiaoliang, Dongsheng Yue, Lei Zhang, et al.. (2022). Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma. Frontiers in Immunology. 13. 794217–794217. 6 indexed citations
7.
Zhang, Qiang, Yu Zhang, Hui Chen, et al.. (2022). METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m 6 A/c-Myc-dependent aerobic glycolysis. Cell Cycle. 21(24). 2602–2614. 21 indexed citations
8.
Qi, Lisha, Changxu Liu, Yuhong Guo, et al.. (2021). A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma. Cancer Biology and Medicine. 18(2). 517–529. 9 indexed citations
9.
10.
Liu, Wei, Shuo Li, Tao Shi, et al.. (2020). A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation. Cancer Research and Treatment. 53(2). 601–606. 5 indexed citations
11.
Wang, Haiyue, Leina Sun, Yaxiong Sang, et al.. (2019). A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy. Lung Cancer. 130. 135–142. 17 indexed citations
12.
Liu, Changxu, Wenjuan Ma, Lisha Qi, et al.. (2019). A combination of tumor and molecular markers predicts a poor prognosis in lung adenocarcinoma.. PubMed. 12(5). 1690–1701. 5 indexed citations
13.
Zhang, Qiang, Bin Zhang, Leina Sun, et al.. (2018). Cisplatin resistance in lung cancer is mediated by <italic>MACC1</italic> expression through PI3K/AKT signaling pathway activation. Acta Biochimica et Biophysica Sinica. 50(8). 748–756. 14 indexed citations
14.
Zhang, Qiang, Bin Zhang, Leina Sun, et al.. (2018). MicroRNA‐130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β‐catenin pathway. Cell Biochemistry and Function. 36(4). 194–202. 51 indexed citations
15.
Wang, Jing, Yanjun Su, Xi Chen, et al.. (2017). Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?. Oncotarget. 8(25). 40594–40605. 2 indexed citations
16.
Han, Ying, Leina Sun, Hongqing Zhuang, et al.. (2016). Platelet–lymphocyte ratio is an independent prognostic factor in patients with ALK -positive non-small-cell lung cancer. Future Oncology. 13(1). 51–61. 19 indexed citations
17.
Jiang, Richeng, et al.. (2011). Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma. Molecular Diagnosis & Therapy. 15(6). 347–352. 68 indexed citations
18.
Sun, Leina, et al.. (2011). Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice. Journal of Experimental & Clinical Cancer Research. 30(1). 30–30. 75 indexed citations
19.
Sun, Leina, et al.. (2010). Study of the correlation of EGFR and K-RAS gene mutations with its protein expression in non-small cell lung cancer. SHILAP Revista de lepidopterología. 7(2). 97–102. 1 indexed citations
20.
Sun, Leina, et al.. (2009). [Expression of coxsackievirus and adenovirus receptor in non-small cell lung cancer and its significance].. PubMed. 31(4). 278–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Vagia Breakdown of academic impact, for papers by Surein Arulananda Breakdown of academic impact, for papers by Hongge Liang Breakdown of academic impact, for papers by W Kitonyi Grace Breakdown of academic impact, for papers by Alberto Verlicchi Breakdown of academic impact, for papers by Qifeng Ding Breakdown of academic impact, for papers by Trine Lindsted Breakdown of academic impact, for papers by Chris Nevala-Plagemann Breakdown of academic impact, for papers by Guiqi Zhu Breakdown of academic impact, for papers by Markus Bernhardt
Rankless by CCL
2026